Dragon III-Phase 3: Neoadjuvant Chemotherapy (FLOT Versus SOX) for Gastric Cancer
Condition(s):Gastric Cancer; Neoadjuvant ChemotherapyLast Updated:July 19, 2021Not yet recruiting
Include Studies Not Open or Pending
Condition(s):Gastric Cancer; Neoadjuvant ChemotherapyLast Updated:July 19, 2021Not yet recruiting
Condition(s):Gastric Cancer; Chemotherapy Effect; Predictive Cancer ModelLast Updated:October 4, 2023Recruiting
Condition(s):Gastric Cancer; Peritoneal CarcinomatosisLast Updated:March 23, 2023Recruiting
Condition(s):Head and Neck Squamous Cell CarcinomaLast Updated:December 26, 2023Recruiting
Condition(s):Colorectal Carcinoma; Chemotherapy; Liver MetastasesLast Updated:March 4, 2021Not yet recruiting
Condition(s):Pancreatic Ductal AdenocarcinomaLast Updated:January 18, 2024Recruiting
Condition(s):CancerLast Updated:February 21, 2023Recruiting
Condition(s):Ovarian Cancer; Intraperitoneal ChemotherapyLast Updated:March 14, 2022Recruiting
Condition(s):Colorectal Cancer; Colorectal Cancer Liver MetastasisLast Updated:July 19, 2022Recruiting
Condition(s):Hyperthermic Intraperitoneal Chemotherapy; Neoadjuvant ChemotherapyLast Updated:February 18, 2022Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.